Lymphoma Trials

Trial No.: Genentech GO40554

Trial Name:

A phase I/II study of BTCT4465A in patients who do not achieve CR to 1L therapy for DLBCL and as 1L therapy for patients unfit to receive full-dose anthracycline-based chemotherapy Regulatory Packet sent to Sponsor.

Trial No.: TG Therapeutics UTX-TGR-205

Trial Name:

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma   OPEN COHORTS: MANTLE CELL, FOLICULAR LYMPHOMA

Fort Wayne North Office
(260) 484-8830
11143 Parkview Plaza Drive, Suite 100
Fort Wayne, Indiana 46845

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.